Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Radiology
Published in: European Radiology 5/2014

01-05-2014 | Contrast Media

The incidence of contrast-induced nephropathy (CIN) following transarterial chemoembolisation (TACE) in patients with hepatocellular carcinoma (HCC)

Authors: Katsumi Hayakawa, Masato Tanikake, Toshihiko Kirishima, Naomi Yoshinami, Hiroyuki Shintani, Eiji Yamamoto, Taisuke Morimoto

Published in: European Radiology | Issue 5/2014

Login to get access

Abstract

Purpose

The purpose of this retrospective study was to investigate the incidence of contrast-induced nephropathy (CIN) caused by transarterial chemoembolisation (TACE) in patients with hepatocellular carcinoma (HCC).

Materials and Methods

One hundred forty-one patients treated between 2005 and 2008 undergoing 305 consecutive sessions of TACE were enrolled. CIN was defined as an increase in the serum creatinine level of more than 0.5 mg/dl or more than 25 % from baseline within 3 days after TACE without any other identifiable cause of acute kidney injury.

Results

CIN by the present definition was observed after 2.6 % of the TACE sessions. No patient showed clinical signs or symptoms of acute renal failure, or required haemodialysis. None of the patients with an estimated glomerular filtration rate of <60 ml/min/1.73 m2 developed CIN.

Conclusion

The present study suggests that TACE is a relatively safe procedure in terms of the risk of CIN under vigorous periprocedural hydration and that the incidence of CIN is comparable to that of AKI associated with intravenous CM administration.

Key points

• CIN would be lower for non-coronary arterial intervention than for coronary intervention.
• The present study suggests that the CIN rates following TACE are low.
• The incidence of CIN is comparable to that after intravenous CM administration.
Literature
1.
Stacul F, van der Molen AJ, Reimer P et al (2011) Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 21:2527–2541PubMedCrossRef
2.
Rihal CS, Textor SC, Grill DE et al (2002) Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105:2259–2264PubMedCrossRef
3.
Lindsay J, Canos DA, Apple S et al (2004) Causes of acute renal dysfunction after percutaneous coronary intervention and comparison of late mortality rates with postprocedure rise of creatinine kinase-MB versus rise of serum creatinine. Am J Cardiol 94:786–789PubMedCrossRef
4.
Taliercio CP, Vlietstra RE, Fisher LD et al (1986) Risks for renal dysfunction with cardiac angiography. Ann Intern Med 104:501–504PubMedCrossRef
5.
Chou SH, Wang ZJ, Kuo J et al (2011) Persistent renal enhancement after intra-arterial versus intravenous iodixanol administration. Eur J Radiol 80:378–386PubMedCentralPubMedCrossRef
6.
Lufft V, Lufft LH, Fels LM et al (2002) Contrast media nephropathy: Intravenous CT angiography versus intraarterial digital subtraction angiography in renal artery stenosis: a prospective randomized trial. Am J Kidney Dis 40:236–242PubMedCrossRef
7.
Ahuja TS, Niaz N, Agraharkar M (2000) Contrast-induced nephrotoxicity in renal allograft recipients. Clin Nephrol 54:11–14PubMed
8.
Gruberg L, Mintz GS, Mehran R et al (2000) The prognostic implication of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 36:1542–1548PubMedCrossRef
9.
Sharma SK, Kini A (2005) Effect of nonionic radiocontrast agents on the occurrence of contrast-induced nephropathy in patients with mild-moderate chronic renal insufficiency: Pooled analysis of the randomized trials. Cathet Cardiovasc Interv 65:386–393CrossRef
10.
Solomon RJ, Natarajan MK, Doucet S et al (2007) Cardiac angiography in renally impaired patients (CARE) study: A randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation 115:3189–3196PubMedCrossRef
11.
Loh Y, McArthur DL, Vespa P et al (2010) The risk of acute radiocontrast-mediated kidney injury following endovascular therapy for acute ischemic stroke is low. Am J Neuroradiol 31:1584–1587PubMedCrossRef
12.
Kato T, Sakai H, Tsujimoto M, Nishimura Y (2011) Prolonged carotid sinus reflex is a risk factor for contrast-induced nephropathy following carotid artery stenting. Am J Neuroradiol 32:441–445PubMedCrossRef
13.
Huo TI, Wu JC, Huang YH et al (2004) Acute renal failure after transarterial chemoembolization for hepatocellular carcinoma: A retrospective study of the incidence, risk factors, clinical course and long-term outcome. Aliment Pharmacol Ther 19:999–1007PubMedCrossRef
14.
Huo TI, Wu JC, Chang FY, Lee SD (2004) Incidence and risk factors for acute renal failure in patients with hepatocellular carcinoma undergoing transarterial chemoembolization: a prospective study. Liver Int 24:210–215PubMedCrossRef
15.
Park J, Chung HC, Lee JS et al (2008) Acute kidney injury after transarterial chemoembolization for hepatocellular carcinoma: A retrospective analysis. Blood Purif 26:454–459PubMedCrossRef
16.
Hsu CY, Huang YH, Su CH et al (2010) Renal failure in patients with hepatocellular carcinoma and ascites undergoing transarterial chemoembolization. Liver Int 30:77–84PubMedCrossRef
17.
Hsu CY, Huang YH, Su CW et al (2010) Transarterial chemoembolization in patients with hepatocellular carcinoma and renal insufficiency. J Clin Gastroenterol 44:e171–e177PubMed
18.
Cho HS, Seo JW, Kang Y et al (2011) Incidence and risk factors for radiocontrast-induced nephropathy in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization. Clin Exp Nephrol 15:714–719PubMedCrossRef
19.
Lee YH, Hsu CY, Huang YH et al (2012) Selecting a prognostic renal surrogate for patients with hepatocellular carcinoma undergoing transarterial chemoembolization. J Gastroenterol Hepatol 27:1581–1588PubMedCrossRef
20.
Katzberg RW, Newhouse JH (2010) Intravenous contrast medium-induced nephrotoxicity: Is the medical risk really as great as we have come to believe? Radiology 256:21–28PubMedCrossRef
21.
Katzberg RW, Barrett BJ (2007) Risk of iodinated contrast material-induced nephropathy with intravenous administration. Radiology 243:622–628PubMedCrossRef
22.
Tepel M, van der Geit M, Schwarzfeld C, Laufer U, Liermann D, Zidek W (2000) Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343:180–184PubMedCrossRef
23.
Becker CR, Reiser MF (2005) Use of iso-osmolar nonionic dimeric contrast media in multidetector row computed tomography angiography of patients with renal impairment. Invest Radiol 40:672–675PubMedCrossRef
24.
Barrett BJ, Katzberg RW, Thomsen HS et al (2006) Contrast-induced nephropathy in patients with chronic kidney disease undergoing computer tomography—a double blind comparison of iodixanol and iopamidol. Invest Radiol 41:815–821PubMedCrossRef
25.
Thomsen HS, Morcos SK, Earley CM et al (2008) The ACTIVE trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography. Invest Radiol 43:170–178PubMedCrossRef
26.
Kuhn MJ, Chen N, Sahani DV et al (2008) The PREDICT study: A randomized double-blind comparison of contrast-induced nephropathy after low- or iso-osmolar contrast agent exposure. Am J Roentgenol 191:151–157CrossRef
27.
Nguyen SA, Suranyi P, Ravenel JG et al (2008) Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function. Radiology 248:97–105PubMedCrossRef
28.
Weisbord SD, Mor MK, Resnick AL, Hartwig KC, Palevsky PM, Fine MJ (2008) Incidence and outcomes of contrast-induced AKI following computed tomography. Clin J Am Soc Nephrol 3:1274–1281PubMedCentralPubMedCrossRef
29.
Moreau R, Lebec D (2003) Acute renal failure in patients with cirrhosis: perspectives in the age of MELD. Hepatology 37:233–243PubMedCrossRef
30.
Barrett BJ, Parfrey PS (1994) Prevention of nephrotoxicity induced by radiocontrast agents. N Engl J Med 331:1449–1450PubMedCrossRef
31.
Guevara M, Fernández-Esparrach G, Alessandria C et al (2004) Effect of contrast media in renal function in patients with cirrhosis: A prospective study. Hepatology 40:646–651PubMedCrossRef
32.
Najar M, Hamad A, Salameh M, Agarwal A, Feinfeld DA (2002) The risk of radiocontrast nephropathy in patients with cirrhosis. Ren Fail 24:11–18CrossRef
33.
Davenport MS, Khalatbari S, Dillman JR, Cohan RH, Caoili EM, Ellis JH (2013) Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material. Radiology 267:94–105PubMedCentralPubMedCrossRef
34.
McDonald RJ, McDonald JS, Bida JP et al (2013) Intravenous contrast material-induced nephropathy: Causal or coincident phenomenon. Radiology 267:106–118PubMedCrossRef
35.
Davenport MS, Khalatbari S, Cohan RH, Dillman JR, Myles JD, Ellis JH (2013) Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: Risk stratification by using estimated glomerular filtration rate. Radiology 268:719–728PubMedCrossRef
Metadata
Title
The incidence of contrast-induced nephropathy (CIN) following transarterial chemoembolisation (TACE) in patients with hepatocellular carcinoma (HCC)
Authors
Katsumi Hayakawa
Masato Tanikake
Toshihiko Kirishima
Naomi Yoshinami
Hiroyuki Shintani
Eiji Yamamoto
Taisuke Morimoto
Publication date
01-05-2014
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 5/2014
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-014-3099-8

Other articles of this Issue 5/2014

European Radiology 5/2014 Go to the issue

Hepatobiliary-Pancreas

Hepatic cysts treated with percutaneous ethanol sclerotherapy: time to extend the indications to haemorrhagic cysts and polycystic liver disease

Breast

Is there any correlation between model-based perfusion parameters and model-free parameters of time-signal intensity curve on dynamic contrast enhanced MRI in breast cancer patients?

Pediatric

Whole-body MRI for initial staging of paediatric lymphoma: prospective comparison to an FDG-PET/CT-based reference standard

Computed Tomography

Assessment of vascular contrast and wall motion of the aortic root and ascending aorta on MDCT angiography: dual-source high-pitch vs non-gated single-source acquisition schemes

Head and Neck

Ultrahigh field magnetic resonance and colour Doppler real-time fusion imaging of the orbit – a hybrid tool for assessment of choroidal melanoma

Gastrointestinal

Training readers to improve their accuracy in grading Crohn’s disease activity on MRI